ABSTRACT
Purpose To investigate the repeatability of a combined Dual-Scheimpflug placido disc corneal topographer (Zeimer Galilei G4) with respect to keratometric indices used to monitor progression of keratoconus (KCN).
Methods Patients with KCN were prospectively enrolled. For each eye lacking history of corneal surgery, 5 measurements were taken in succession. Eyes in which 3 or more measurements could be obtained (defined by the device’s 4 image quality metrics) were included in the analysis. The repeatability limits (RL) and interclass correlation coefficients (ICC) were calculated for various parameters.
Results 32 eyes from 25 patients met all image quality metrics, and 54 eyes from 38 patients met at least 3/4 criteria (all except the placido image quality metric). RLs for key parameters when 4/4 or ≥3/4 image quality metrics were met included: 0.37 and 0.77 diopters (D) for steep simulated keratometry, 0.79 and 1.65 D for maximum keratometry, 13.80 and 13.88 degrees for astigmatism axis, 0.64 and 0.56 μm for vertical coma magnitude, and 3.76 and 3.84 μm for thinnest pachymetry, respectively. The ICCs for all parameters were excellent [above 0.87 except for spherical aberration (0.77)].
Conclusions The dual-Scheimpflug placido disc corneal topographer is highly repeatable in quantifying parameters used in monitoring KCN. Excellent placido images are difficult to capture in eyes with KCN, but when available, increase the reliability of the measurements. The RLs may be especially helpful in detecting progression in mild KCN when interventions such as corneal cross-linking or intrastromal corneal ring segments are most beneficial.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT03511495
Funding Statement
No external funding was received in relation to this project.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Full dataset may be available to interested parties by request. Please e-mail the corresponding author to query.
